REGENXBIO INC (RGNX) Stock Balance Sheet
NASDAQ:RGNX - US75901B1070 - Common Stock
9.01 USD
+0.19 (+2.15%)
9.01 USD
0 (0%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 79.56M | 57.53M | 34.52M | 97.00M | 345.20M | |||
| Marketable Securities | 243.74M | 177.16M | 240.74M | 267.70M | 112.20M | |||
| Receivables | 38.48M | 20.47M | 24.79M | 28.10M | 32.40M | |||
| Other Current Assets | 11.98M | 22.84M | 34.92M | 23.30M | 29.00M | |||
| Total Current Assets | 373.75M | 278.00M | 334.97M | 416.00M | 518.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 161.49M | 171.31M | 192.59M | 206.80M | 192.50M | |||
| Investments And Advances | 40.30M | 10.18M | 38.87M | 200.60M | 391.90M | |||
| Other Non-Current Assets | 3.91M | 6.03M | 6.84M | 8.40M | 8.50M | |||
| Total Non-Current Assets | 207.28M | 187.99M | 239.00M | 417.30M | 595.10M | |||
| TOTAL ASSETS | 581.03M | 465.99M | 573.97M | 833.30M | 1.11B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 43.61M | 45.97M | 56.77M | 52.80M | 66.50M | |||
| Accounts Payable | 21.66M | 22.80M | 22.79M | 27.20M | 11.40M | |||
| Other Current Liabilities | 54.28M | 34.42M | 50.72M | 50.40M | 52.50M | |||
| Total Current Liabilities | 119.54M | 103.19M | 130.27M | 130.40M | 130.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 247.81M | 103.14M | 131.96M | 186.60M | 219.10M | |||
| Total Non-Current Liabilities | 247.81M | 103.14M | 131.96M | 186.70M | 219.10M | |||
| TOTAL LIABILITIES | 367.35M | 206.34M | 262.23M | 317.10M | 349.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -996.94M | -932.15M | -705.05M | -441.60M | -161.20M | |||
| Additional Paid In Capital | 1.21B | 1.19B | 1.02B | 973.10M | 928.10M | |||
| Common Shares | 5.00K | 5.00K | 4.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -750.00K | -741.00K | -4.43M | -15.40M | -2.60M | |||
| Shares Outstanding | 50.39M | 49.55M | 44.05M | 43.30M | 42.80M | |||
| Tangible Book Value per Share | 4.24 | 5.24 | 7.08 | 11.92 | 17.86 | |||
| Total Shareholders' Equity | 213.68M | 259.65M | 311.74M | 516.20M | 764.30M | |||
| TOTAL LIABILITIES AND EQUITY | 581.03M | 465.99M | 573.97M | 833.30M | 1.11B | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 3.13 | 2.69 | 2.57 | 3.19 | 3.98 | |||
| Return On Assets (ROA) | -30.22% | -48.74% | -45.91% | -33.64% | 11.47% | |||
| Return On Equity (ROE) | -82.17% | -87.46% | -84.52% | -54.30% | 16.72% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | 12.85% | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | 24.03% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | N/A | N/A | 24.03% | |||
All data in USD , ROIC based on taxRate of 0.21